Literature DB >> 26215779

Electrophysiologic Results After Thoracoscopic Ablation for Chronic Atrial Fibrillation.

Young Keun On1, Kyoung-Min Park1, Dong Seop Jeong2, Pyo Won Park3, Young Tak Lee3, Seung-Jung Park1, June Soo Kim1.   

Abstract

BACKGROUND: Thoracoscopic ablation for lone atrial fibrillation (AF) has evolved rapidly in the past decade. We investigated the electrophysiologic results and midterm durability of totally thoracoscopic ablation in patients with lone persistent AF.
METHODS: Seventy-nine consecutive patients with paroxysmal AF (8 patients, 10.1%), persistent AF (17 patients, 21.5%), and long-standing persistent AF (54 patients, 68.3%) were prospectively enrolled. Thoracoscopic ablation consisted of a bilateral closed-chest approach to performing pulmonary isolation (a box lesion), ganglionated plexus ablation, division of the Marshall ligament, and left atrial auricle resection. An electrophysiologic study was performed 5 days after the surgical procedure in 61 patients (77%). Freedom from AF was assessed with electrocardiograms or Holter monitoring every 3 months, with a mean follow-up of 12.1 (maximum, 28) months.
RESULTS: No deaths or conversion to cardiopulmonary bypass occurred. During electrophysiologic study, 28 residual pulmonary vein potentials were observed in 15 patients (19%). Out of a total of 28 gaps, 20 (71%) were located in the superior and inferior ridges of pulmonary veins. Six gaps (21%) were detected in the carina of pulmonary veins. The mitral isthmus was ablated in 2 patients (7%). Freedom from AF at 2 years was 92.6 ± 3.3%. Freedom from cardiac-related events at 2 years was 74.7 ± 6.0%. Cox regression analysis demonstrated that the predictors of atrial arrhythmias were old age, hypertension, and left atrial volume index.
CONCLUSIONS: Thoracoscopic ablation followed by electrophysiologic confirmation was safe and provided excellent midterm durability in patients with AF. However, the incidence of residual potentials around the pulmonary veins was not negligible.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26215779     DOI: 10.1016/j.athoracsur.2015.04.127

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  The future of hybrid ablation: an emerging need for an anticoagulation protocol for thoracoscopic ablation.

Authors:  Pavel Osmancik; Petr Budera
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  Midterm outcomes of two-staged hybrid ablation of persistent and long-standing persistent atrial fibrillation using the versapolar epicardial surgical device and subsequent catheter ablation.

Authors:  Petr Budera; Pavel Osmancik; Dalibor Herman; Jana Zdarska; David Talavera; Anna Mala; Radka Prochazkova; Zbynek Straka
Journal:  J Interv Card Electrophysiol       Date:  2017-09-18       Impact factor: 1.900

3.  Staged hybrid procedure in persistent atrial fibrillation: safety, efficacy, and atrial tachyarrhythmia.

Authors:  Min Suk Choi; Dong Seop Jeong
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

4.  Surgical perspective on hybrid ablation for non-paroxysmal atrial fibrillation.

Authors:  Yuyuan Zhang; Huiming Guo
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

Review 5.  Surgical Ablation of Atrial Fibrillation: is Electrical Isolation of the Pulmonary Veins a Must?

Authors:  Bart Maesen; Ines Van-Loo; Laurent Pison; Mark La-Meir
Journal:  J Atr Fibrillation       Date:  2016-06-30

6.  Mid-Term Results of Totally Thoracoscopic Ablation in Patients with Recurrent Atrial Fibrillation after Catheter Ablation.

Authors:  Suk Kyung Lim; Joo Yeon Kim; Young Keun On; Dong Seop Jeong
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2020-10-05

7.  Thoracoscopic Implantation of Epicardial Left Ventricular Lead for Cardiac Resynchronization Therapy.

Authors:  Hye Ree Kim; Kyunghee Lim; Seung-Jung Park; Jong-Sung Park; Ju Youn Kim; Suryeun Chung; Dong-Seop Jung; Kyoung-Min Park; Young Keun On; June Soo Kim
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-16

8.  Effectiveness of the Early Staged Hybrid Approach for Treatment of Symptomatic Atrial Fibrillation: the Electrophysiology Study Could Be Deferred?

Authors:  Ju Youn Kim; Dong Seop Jeong; Hee-Jin Kwon; Seung-Jung Park; Kyoung-Min Park; June Soo Kim; Young Keun On
Journal:  J Korean Med Sci       Date:  2021-11-08       Impact factor: 2.153

9.  Long-Term Efficacy and Anticoagulation Strategy of Left Atrial Appendage Occlusion During Total Thoracoscopic Ablation of Atrial Fibrillation to Prevent Ischemic Stroke.

Authors:  Ju Youn Kim; Dong Seop Jeong; Seung-Jung Park; Kyoung-Min Park; June Soo Kim; Young Keun On
Journal:  Front Cardiovasc Med       Date:  2022-03-31

10.  Staged hybrid procedure versus radiofrequency catheter ablation in the treatment of atrial fibrillation.

Authors:  Jin Kyung Hwang; Dong Seop Jeong; Hye Bin Gwag; Kyoung-Min Park; Joonghyun Ahn; Keumhee Carriere; Seung-Jung Park; June Soo Kim; Young Keun On
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.